Literature DB >> 8566965

The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D.

E Schröck1, P Badger, D Larson, M Erdos, A Wynshaw-Boris, T Ried, L Brody.   

Abstract

The recently cloned human breast and ovarian cancer susceptibility gene, BRCA1, is located on human chromosome 17q21. We have isolated murine genomic clones containing Brca1 as a first step in generating a mouse model for the loss of BRCA1 function. A mouse genomic library was screened using probes corresponding to exon 11 of the human BRCA1 gene. Two overlapping mouse clones were identified that hybridized to human BRCA1 exons 9-12. Sequence analysis of 1.4 kb of the region of these clones corresponding to part of human exon 11 revealed 72% nucleic acid identity but only 50% amino acid identity with the human gene. The longest of the mouse Brca1 genomic clones maps to chromosome 11D, as determined by two-color fluorescence in situ hybridization. The synteny to human chromosome 17 was confirmed by cohybridization with the mouse probe for the NF1-gene. This comparative study confirms that the relative location of the BRCA1 gene has been conserved between mice and humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566965     DOI: 10.1007/bf02265277

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Simultaneous visualization of seven different DNA probes by in situ hybridization using combinatorial fluorescence and digital imaging microscopy.

Authors:  T Ried; A Baldini; T C Rand; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

2.  The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues.

Authors:  S T Marquis; J V Rajan; A Wynshaw-Boris; J Xu; G Y Yin; K J Abel; B L Weber; L A Chodosh
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

3.  Mouse chromosome 11.

Authors:  A C Lossie; M MacPhee; A M Buchberg; S A Camper
Journal:  Mamm Genome       Date:  1994       Impact factor: 2.957

Review 4.  A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.

Authors:  W H Li; C I Wu; C C Luo
Journal:  Mol Biol Evol       Date:  1985-03       Impact factor: 16.240

5.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

6.  Mammalian gene evolution: nucleotide sequence divergence between mouse and rat.

Authors:  K H Wolfe; P M Sharp
Journal:  J Mol Evol       Date:  1993-10       Impact factor: 2.395

7.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments.

Authors:  A Bernards; A J Snijders; G E Hannigan; A E Murthy; J F Gusella
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

9.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Authors:  D Shattuck-Eidens; M McClure; J Simard; F Labrie; S Narod; F Couch; K Hoskins; B Weber; L Castilla; M Erdos
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

View more
  5 in total

Review 1.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

2.  SHOT, a SHOX-related homeobox gene, is implicated in craniofacial, brain, heart, and limb development.

Authors:  R J Blaschke; A P Monaghan; S Schiller; B Schechinger; E Rao; H Padilla-Nash; T Ried; G A Rappold
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Cloning of the human NADH: ubiquinone oxidoreductase subunit B13: localization to chromosome 7q32 and identification of a pseudogene on 11p15.

Authors:  M W Russell; S du Manoir; F S Collins; L C Brody
Journal:  Mamm Genome       Date:  1997-01       Impact factor: 2.957

4.  Genomic organization of the murine Miller-Dieker/lissencephaly region: conservation of linkage with the human region.

Authors:  S Hirotsune; S D Pack; S S Chong; C M Robbins; W J Pavan; D H Ledbetter; A Wynshaw-Boris
Journal:  Genome Res       Date:  1997-06       Impact factor: 9.043

5.  Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.

Authors:  S Sharif; A Moran; S M Huson; R Iddenden; A Shenton; E Howard; D G R Evans
Journal:  J Med Genet       Date:  2007-03-16       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.